Temelimab as a Disease Modifying Therapy in Patients With Neuropsychiatric Symptoms in Post-COVID 19 or PASC Syndrome

Clinical trial NCT05497089 · COMPLETED

Trial details

NCT number: NCT05497089
Sponsor: GeNeuro SA
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Post-COVID-19 Syndrome

Start date: 2022-08-29
Primary completion: 2024-05-10
Enrollment: 203

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.